Literature DB >> 33906858

Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'.

Serena Bugatti1,2, Silvia Balduzzi3, Ludovico De Stefano3,2, Antonio Manzo3,2, Blerina Xoxi3, Laura Bogliolo3, Sara Monti3,2, Paolo Delvino3,2, Carlomaurizio Montecucco3,2.   

Abstract

Entities:  

Keywords:  Covid-19; biological therapy; vaccination

Mesh：

Substances：

Year:  2021        PMID： 33906858     DOI： 10.1136/annrheumdis-2021-220541

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases.

Authors:  Guillermo Guaracha-Basáñez; Irazú Contreras-Yáñez; Everardo Álvarez-Hernández; Carla Marina Román-Montes; Graciela Meza-López Y Olguín; María José Morales-Graciano; Salvador Saúl Valverde-Hernández; Ingris Peláez-Ballestas; Virginia Pascual-Ramos
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

2.  Immunogenicity 6 months post COVID-19 mRNA-vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors.

Authors:  Dimitra Dimopoulou; Maria N Tsolia; Nikos Spyridis; Despoina N Maritsi
Journal:  Rheumatology (Oxford)       Date:  2022-07-05       Impact factor: 7.046

3.  Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

Authors:  Anna Carolina Faria Moreira Gomes Tavares; Ana Karla Guedes de Melo; Vítor Alves Cruz; Viviane Angelina de Souza; Joana Starling de Carvalho; Ketty Lysie Libardi Lira Machado; Lilian David de Azevedo Valadares; Edgard Torres Dos Reis Neto; Rodrigo Poubel Vieira de Rezende; Maria Fernanda Brandão de Resende Guimarães; Gilda Aparecida Ferreira; Alessandra de Sousa Braz; Rejane Maria Rodrigues de Abreu Vieira; Marcelo de Medeiros Pinheiro; Sandra Lúcia Euzébio Ribeiro; Blanca Elena Gomes Rios Bica; Kátia Lino Baptista; Izaias Pereira da Costa; Claudia Diniz Lopes Marques; Maria Lúcia Lemos Lopes; José Eduardo Martinez; Rina Dalva Neubarth Giorgi; Lícia Maria Henrique da Mota; Marcos Antônio Araújo da Rocha Loures; Eduardo Dos Santos Paiva; Odirlei André Monticielo; Ricardo Machado Xavier; Adriana Maria Kakehasi; Gecilmara Cristina Salviato Pileggi
Journal:  Adv Rheumatol       Date:  2022-01-17

Review 4.  Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review.

Authors:  Pamir Atagündüz; Gökhan Keser; Mehmet Soy
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

Review 5.  A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.

Authors:  Young Hun Jeon; Doo-Ho Lim; Seung Won Choi; Su Jin Choi
Journal:  Rheumatol Int       Date:  2021-11-19       Impact factor: 3.580

6.  Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study.

Authors:  Guillermo Arturo Guaracha-Basañez; Irazú Contreras-Yáñez; Everardo Álvarez-Hernández; Greta Reyes-Cordero; Diana Elsa Flores-Alvarado; Susana Aidée González-Chávez; Dionicio Ángel Galarza-Delgado; Perla Rocío Martínez-Leyva; José Francisco Moctezuma-Ríos; Conrado García-García; Gabriel Medrano-Ramírez; Alfonso Gastelum-Strozzi; César Pacheco-Tena; Ingris Peláez-Ballestas; Virginia Pascual-Ramos
Journal:  Hum Vaccin Immunother       Date:  2022-04-07       Impact factor: 4.526
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.